FindTrial
Sign In

Comparison of two intravenous anaesthetic regimens in women undergoing hysterectomy surgery

Comparison of pharmacokinetic models-schnider vs eleveld using propofol based target-controlled infusion in total laparoscopic hysterectomy surgeries. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107750
Enrollment
60
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N719- Inflammatory disease of uterus, unspecified Health Condition 2: N99-N99- Intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

JOIS NIKHITHA CHAR
Lead Sponsor
SAKRA WORLD HOSPITAL
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.PATIENTS BELONGING TOP AMERICAN SOCIETY OF ANAESTHESIOLOGISTS (ASA) I OR II. 2.SCHEDULED FOR ELECTIVE TOTAL LAPAROSCOPIC HYSTERECTOMY SURGERY AND REQUIRING GENERAL ANAESTHESIA AND ENDOTRACHEAL INTUBATION. 3.PATIENTS WHO ARE WILLING TO BE PART OF THE STUDY.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
TO RECORD THE CONCENTRATION OF PROPOFOL AT EFFECT SITE(Ce) AT LOSS OF RESPONSIVENESS(LoR) GUIDED CLINICALLY AND CORROBORATED BY BISPECTRAL INDEX (BIS)Timepoint: BASELINE-AT INDUCTION OF ANAESTHESIA—

Secondary

MeasureTime frame
1.TO RECORD THE CONCENTRATION OF PROPOFOL AT EFFECT SITE (Ce) AT RETURN OF RESPONSIVENESS (RoR). 2.TO RECORD THE TOTAL PROPOFOL CONSUMPTION AT THE END OF SURGERY. 3.HEMODYNAMIC STABILITY (HR,BP)Timepoint: BASELINE- RECORDED AT EMERGENCE,END OF ANESTHESIA—

Countries

India

Contacts

Public ContactJOIS NIKHITHA CHAR

SAKRA WORLD HOSPITAL

shishir.c@sakraworldhospital.com9663841802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026